ARK Investment Management LLC 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 4:01 pm Purchase |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 34,504,273 12.900% |
8,812,592 (+34.30%) |
Filing |
| 2023-02-10 1:48 pm Sale |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 25,691,681 11.360% |
-691,422 (-2.62%) |
Filing |
| 2022-02-09 2:45 pm Sale |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 26,383,103 11.960% |
-2,121,526 (-7.44%) |
Filing |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 28,504,629 15.320% |
8,659,849 (+43.64%) |
Filing |
| 2020-10-09 2:00 pm Purchase |
2020-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 19,844,780 11.230% |
19,844,780 (New Position) |
Filing |